Details for 2016736667

Up to date per 03.04.2026

Actions

Title / Product Name

NEUARTIGE PD-1-IMMUNMODULIERENDE MITTEL

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016736667

EP Publication Number

3313883

E-Number

1638328

Language

PCT Number

US16039015

Publication Date

02.05.2018 A

06.12.2023 B1

Registration Date

06.12.2023

AT Publication Date

15.12.2023

Application Date

23.06.2016

Registration Number

Priorities

23.06.2015

201562183297 P

11.12.2015

201562266398 P

IPC

C07K 16/28 20060101AFI20230619BHEP

Maximum Duration of Protection

23.06.2036

Owner

Memorial Sloan Kettering Cancer Center1275 York Avenue New York, NY 10065US

Eureka Therapeutics, Inc.5858 Horton Street, Suite 370 Emeryville, CA 94608US

Representative

No representatives present

Inventor

BRENTJENS, Renier J.140 Old Short Hills Road Short Hills, New Jersey 07078US

JACKSON, Hollie Jaine111 Hambleton St. Middle Park, VIC 3206AU

LIU, Cheng4 Commodore Drive D334 Emeryville, California 94608US